by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerWarning LettersEhsan Sadri, M.D.

All Warning Letters

Ehsan Sadri, M.D.

Warning LetterOpen

Ehsan Sadri, M.D., 361 Hospital Road, Suite 324 Newport Beach , CA 92663-3524 United StatesIssued Mar 27, 2026Center for Drug Evaluation and Research (CDER)

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations1

Issue DateMar 27, 2026

Product TypeDrugs

StatusOpen

Letter Details

Firm: Ehsan Sadri, M.D.
Location: Ehsan Sadri, M.D., 361 Hospital Road, Suite 324 Newport Beach , CA 92663-3524 United States
FEI Number: N/A
Country: United States
Issue Date: March 27, 2026
Issuing Office: Center for Drug Evaluation and Research (CDER)
Product Type: Drugs
Status: Open

Subject

Clinical Investigator

Ehsan Sadri, M.D. FDA Warning Letter, March 27, 2026